No abstract available
MeSH terms
-
Activin Receptors, Type II* / therapeutic use
-
COVID-19 Vaccines* / adverse effects
-
COVID-19* / prevention & control
-
Humans
-
Immunoglobulin Fc Fragments* / therapeutic use
-
Recombinant Fusion Proteins / therapeutic use
-
Vaccination
-
beta-Thalassemia* / complications
-
beta-Thalassemia* / drug therapy
Substances
-
Activin Receptors, Type II
-
COVID-19 Vaccines
-
Immunoglobulin Fc Fragments
-
luspatercept
-
Recombinant Fusion Proteins